Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROGRESS: Progressive vs Sudden Esomeprazole Withdrawal
NCT02476097Phase 4Unknown
- Start
- Jun 2015
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole in Rebound acid hypersecretion (RAHS). Status: unknown.
02
Drugs
esomeprazole
03
Conditions
Rebound acid hypersecretion (RAHS)
Beyond the preview
Go deeper on NCT02476097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02476097.